Bank of America’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $359K | Sell |
|
|||||
|
2025
Q2 | $431K | Sell |
|
|||||
|
2025
Q1 | $397K | Buy |
|
|||||
|
2024
Q4 | $46.1K | Sell |
|
|||||
|
2024
Q3 | $7.35M | Buy |
|
|||||
|
2024
Q2 | $7.73M | Buy |
|
|||||
|
2024
Q1 | $9.02M | Buy |
|
|||||
|
2023
Q4 | $115K | Buy |
|
|||||
|
2023
Q3 | $119K | Sell |
|
|||||
|
2023
Q2 | $1.19M | Sell |
|
|||||
|
2023
Q1 | $9.01M | Buy |
|
|||||
|
2022
Q4 | $2.57M | Buy |
|
|||||
|
2022
Q3 | $2.28M | Buy |
|
|||||
|
2022
Q2 | $597K | Sell |
|
|||||
|
2022
Q1 | $2.69M | Buy |
|
|||||
|
2021
Q4 | $1.39M | Buy |
|
|||||
|
2021
Q3 | $472K | Buy |
|
|||||
|
2021
Q2 | $317K | Sell |
|
|||||
|
2021
Q1 | $391K | Buy |
|
|||||
|
2020
Q4 | $314K | Sell |
|
|||||
|
2020
Q3 | $397K | Sell |
|
|||||
|
2020
Q2 | $595K | Sell |
|
|||||
|
2020
Q1 | $1.58M | Buy |
|
|||||
|
2019
Q4 | $637K | Sell |
|
|||||
|
2019
Q3 | $704K | Sell |
|
|||||
|
2019
Q2 | $3.52M | Buy |
|
|||||
|
2019
Q1 | $2.8M | Buy |
|
|||||
|
2018
Q4 | $558K | Buy |
|
|||||
|
2018
Q3 | $642K | Sell |
|
|||||
|
2018
Q2 | $1.49M | Sell |
|
|||||
|
2018
Q1 | $1.62M | Buy |
|
|||||
|
2017
Q4 | $935K | Sell |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $749K | Sell |
|
|||||
|
2017
Q1 | $1.65M | Buy |
|
|||||
|
2016
Q4 | $638K | Buy |
|
|||||
|
2016
Q3 | $159K | Sell |
|
|||||
|
2016
Q2 | $4.72M | Sell |
|
|||||
|
2016
Q1 | $9.61M | Buy |
|
|||||
|
2015
Q4 | $9.85M | Sell |
|
|||||
|
2015
Q3 | $11.7M | Buy |
|
|||||
|
2015
Q2 | $863K | Buy |
|
|||||
|
2015
Q1 | $186K | Sell |
|
|||||
|
2014
Q4 | $367K | Sell |
|
|||||
|
2014
Q3 | $304K | Buy |
|
|||||
|
2014
Q2 | $4K | Sell |
|
|||||
|
2014
Q1 | $27K | Sell |
|
|||||
|
2013
Q4 | $80K | Buy |
|
|||||
|
2013
Q3 | $1K | Sell |
|
|||||
|
2013
Q2 | $86K | Buy |
|